Mechanism of Action Video of Lenabasum

View Video

Overview

Latest Financial Results

Stock Information

Symbol

NASDAQ: CRBP

Price

Loading...

Change

Loading...

MKT Cap

Loading...

Volume

Loading...

Company Overview

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.